This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Emergent BioSolutions Inc (EBS)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 522.79M 450.14M 312.75M 281.89M
Cost of Sales 88.96M 85.96M 43.17M 34.88M
Gross Operating Profit 433.83M 364.18M 269.58M 247.01M
Selling, General, and Administrative Expenses 148.46M 122.84M 87.88M 76.02M
Research & Development 154.00M 150.83M 119.93M 120.23M
Operating Income before D & A (EBITDA) 131.37M 90.51M 61.76M 50.76M
Depreciation & Amortization 35.34M 32.45M 18.96M 11.20M
Interest Income 572.00K 320.00K 139.00K 134.00K
Other Income - Net -319.00K 2.93M 426.00K 1.97M
Special Income / Charges 0.00 0.00 0.00 -9.60M
Total Income Before Interest Expenses (EBIT) 96.29M 61.30M 43.37M 32.07M
Interest Expense 6.52M 8.24M 0.00 6.00K
Pre-Tax Income 89.77M 53.06M 43.37M 32.06M
Income Taxes 26.90M 16.32M 13.11M 13.92M
Minority Interest 0.00 0.00 -876.00K -5.38M
Net Income From Continuing Operations 62.87M 36.74M 30.26M 18.14M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 62.87M 36.74M 30.26M 18.14M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 62.87M 36.74M 31.14M 23.52M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
62.87M 36.74M 30.26M 27.74M
Preferred Dividends
Net Income Available To Common 62.87M 36.74M 30.26M 18.14M
Basic EPS from Continuing Ops. 1.63 0.98 0.86 0.65
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.63 0.98 0.86 0.65
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.63 0.98 0.86 0.65
Basic Normalized Net Income/Share 1.63 0.98 0.86 1.00
EPS fr Continuing Ops. 1.33 0.80 0.85 0.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.33 0.80 0.85 0.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.08 0.08 0.00 0.00
EPS, Total 1.41 0.88 0.85 0.65
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.33 0.80 0.85 0.99
Dividends Paid per Share 0.00 0.00 0.00 0.00
EBS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

EBS Emergent BioSolutions Inc

Chart of EBS

Analysts Ratings for EBS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET EBS ANALYST REPORT

EBS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs